This is the authors' abstract. We don't add key points for this paper.
It is well-documented that serotonin (5-HT) exerts its pharmacological effects through a series of 5-HT receptors. The most recently identified member of this family, 5-HT 7, was first identified in 1993. Over the course of the last 25 years, this receptor has been the subject of intense investigation, and it has been demonstrated that 5-HT 7 plays an important role in a wide range of pharmacological processes. As a result of these findings, modulation of 5-HT 7 activity has been the focus of numerous drug discovery and development programs. This review provides an overview of the roles of 5-HT 7 in normal physiology and the therapeutic potential of this interesting drug target.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Blattner et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: